H Lundbeck A/S (0ND5)
London Exchange · UK · prices in DKK · close of 15 Oct 2026
Key indicators
| Last close | DKK 47.65 |
|---|---|
| 52-week range | 34.48 – 47.94 |
| Return, 1 month / 3 months | +13.5% / +12.1% |
| Return, 1 year / 3 years | +7.7% / +32.3% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 29.9% |
| Worst drawdown (1 year) | -22.4% |
| Average daily value traded | 4.59M DKK |
| Dividend yield | 2.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
H Lundbeck A/S is a pharmaceutical company based in Copenhagen, Denmark, that focuses on medicines for disorders of the brain. It develops and supplies treatments for conditions such as depression, schizophrenia, Alzheimer's disease, Parkinson's disease and epilepsy. Its customers are doctors, hospitals and healthcare systems that use its prescription medicines, and it operates in markets around the world through its own sales organisations and partners.
The shares are listed on the London Exchange in UK under the code 0ND5, and the price on this page is in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
H Lundbeck A/S (0ND5) trades on the London Exchange in UK. It last closed at DKK 47.65 on 15 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 690 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.7% and over the last three months it rose 12.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.2% | ||
| From 52-week high | 0.0% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 12.1% | ||
| 6-month return | 17.7% | ||
| 12-month return, skipping the last month | -5.1% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.4% | ||
| Liquidity | 67 · Fair | Moderate trading activity. | |
| Average daily value traded | 4.59M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.4% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.6% |
|---|---|
| 1 month | +13.5% |
| 3 months | +12.1% |
| 6 months | +17.7% |
| 1 year | +7.7% |
| 3 years | +32.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 43.51 / 41.71 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.94 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Mar 2026 | DKK 1.1500 |
| 27 Mar 2025 | DKK 0.9500 |
| 21 Mar 2024 | DKK 0.7000 |
| 22 Mar 2023 | DKK 0.5800 |
| 24 Mar 2022 | DKK 1.5831 |
| 24 Mar 2021 | DKK 1.9789 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.